- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/712 - Nucleic acids or oligonucleotides having modified sugars, i.e. other than ribose or 2'-deoxyribose
Patent holdings for IPC class A61K 31/712
Total number of patents in this class: 1669
10-year publication summary
|
90
|
101
|
104
|
121
|
157
|
148
|
153
|
178
|
155
|
2
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Ionis Pharmaceuticals, Inc. | 839 |
123 |
| Alnylam Pharmaceuticals, Inc. | 1128 |
47 |
| F. Hoffmann-La Roche AG | 7942 |
30 |
| Hoffmann-La Roche Inc. | 3252 |
30 |
| Nippon Shinyaku Co., Ltd. | 317 |
26 |
| Osaka University | 3288 |
26 |
| Sarepta Therapeutics, Inc. | 359 |
24 |
| Roche Innovation Center Copenhagen A/S | 143 |
24 |
| Wave Life Sciences Ltd. | 165 |
23 |
| University of Massachusetts | 2188 |
21 |
| Avidity Biosciences, Inc. | 125 |
19 |
| Isis Pharmaceuticals, Inc. | 229 |
17 |
| National Center of Neurology and Psychiatry | 145 |
15 |
| Centre National de La Recherche Scientifique | 10052 |
14 |
| Arrowhead Pharmaceuticals, Inc. | 295 |
14 |
| Replicor Inc. | 30 |
14 |
| Sirnaomics, Inc. | 113 |
14 |
| Nissan Chemical Corporation | 1879 |
14 |
| CuRNA, Inc. | 144 |
13 |
| Santaris Pharma A/S | 56 |
13 |
| Other owners | 1148 |